Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
2,802
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus

Yao DengMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Jiaming LanMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina;Department of Pathogenic BiologyHebei Medical University050017ShijiazhuangHeibei ProvinceChina
,
Linlin BaoInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
,
Baoying HuangMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Fei YeMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Yingzhu ChenMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Yanfeng YaoInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
,
Wenling WangMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Chuan QinInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
&
Wenjie TanMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChinaCorrespondence[email protected]
 show all
Pages 1-10 | Received 01 Sep 2017, Accepted 11 Feb 2018, Published online: 04 Apr 2018

References

  • ZakiAMvan BoheemenSBestebroerTMOsterhausADFouchierRAIsolation of a novel coronavirus from a man with pneumonia in Saudi ArabiaNew Engl. J. Med.2012367 1814 182010.1056/NEJMoa1211721
  • van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio3, 10.1128/mBio.00473-12 (2012).
  • ChanJFMiddle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol. Rev.20152846552210.1128/CMR.00102-144402954
  • OkbaNMRajVSHaagmansBLMiddle East respiratory syndrome coronavirus vaccines: current status and novel approachesCurr. Opin. Virol.201723495810.1016/j.coviro.2017.03.007
  • ModjarradKA roadmap for MERS-CoV research and product development: report from a World Health Organization consultationNat. Med.20162270170510.1038/nm.4131
  • AgnihothramSEvaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronavirusesJ. Infect. Dis.2014209995100610.1093/infdis/jit609
  • HaagmansBLAn orthopoxvirus-based vaccine reduces virus excretion after mers-cov infection in dromedary camelsScience2016351778110.1126/science.aad1283
  • ChiHDNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in miceVaccine2017352069207510.1016/j.vaccine.2017.02.063
  • MuthumaniKA synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primatesSci. Transl. Med.20157301ra13210.1126/scitranslmed.aac74624573558
  • ColemanCMMERS-CoV spike nanoparticles protect mice from MERS-CoV infectionVaccine2017351586158910.1016/j.vaccine.2017.02.0125423355
  • WangLEvaluation of candidate vaccine approaches for MERS-CoVNat. Commun.2015610.1038/ncomms87124525294
  • LuGMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26Nature201350022723110.1038/nature12328
  • LiuWJProtective T cell responses featured by concordant recognition of middle east respiratory syndrome coronavirus-derived CD8+ T cell epitopes and host MHCJ. Immunol.201719887388210.4049/jimmunol.1601542
  • TaiWA recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infectionVirology201649937538210.1016/j.virol.2016.10.0055167628
  • LanJTailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigenPLoS ONE20149e11260210.1371/journal.pone.01126024236105
  • JiamingLThe recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infectionVaccine201735101810.1016/j.vaccine.2016.11.064
  • LanJRecombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against middle east respiratory syndrome coronavirus challengeEBioMedicine201521438144610.1016/j.ebiom.2015.08.0314634622
  • GuoXSystemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirusImmunology201514547648410.1111/imm.124624515128
  • ZhangNIdentification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirusCell. Mol. Immunol.20151318019010.1038/cmi.2015.034786625
  • Agrawal A. S., et al. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Human vaccines & immunotherapeutics, 1–6, 10.1080/21645515.2016.1177688 (2016).
  • BollesMA double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challengeJ. Virol.201185122011221510.1128/JVI.06048-113209347
  • Honda-OkuboYSevere acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathologyJ. Virol.2015892995300710.1128/JVI.02980-14
  • Iwata-YoshikawaNEffects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALBc mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccineJ. Virol.2014888597861410.1128/JVI.00983-144135953
  • TsengCTImmunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virusPLoS ONE20127e3542110.1371/journal.pone.00354213335060
  • DemingDVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsPLoS Med.20063e52510.1371/journal.pmed.00305251716185
  • YasuiFPrior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoVJ. Immunol.20081816337634810.4049/jimmunol.181.9.6337
  • ShirotaHKlinmanDMRecent progress concerning CpG DNA and its use as a vaccine adjuvantExpert Rev. Vaccin.20141329931210.1586/14760584.2014.863715
  • KapikianAZMitchellRHChanockRMShvedoffRAStewartCEAn epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccineAm. J. Epidemiol.19698940510.1093/oxfordjournals.aje.a120954
  • ChuaiXPoly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boostingPLoS ONE20138e5412610.1371/journal.pone.00541263545998
  • ChenHImpact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C miceChin. J. Biotechnol.20102674
  • ChenYA novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinEmerg. Microbes Infect.20176e3710.1038/emi.2017.185520482
  • WangYProkaryotic expression, purification and identification of the N protein of middle east respiratory syndrome coronavirusChinese Journal of Microbiology and Immunology201487Chinese Journal of Microbiology and Immunology764769
  • SongFMiddle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodiesJ. Virol.201387119501195410.1128/JVI.01672-133807317
  • DuLMERS-CoV spike protein: a key target for antiviralsExpert Opin. Ther. Targets20172113114310.1080/14728222.2017.1271415
  • PengHLong-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patientsVirology200635146647510.1016/j.virol.2006.03.036
  • PangHProtective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccineJ. Gen. Virol.2004853109311310.1099/vir.0.80111-0
  • BuchholzUJContributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProc. Natl Acad. Sci. USA20041019804980910.1073/pnas.0403492101470755
  • ArmstrongJNiemannHSmeekensSRottierPWarrenGSequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirusNature198430875175210.1038/308751a0
  • PervushinKStructure and inhibition of the SARS coronavirus envelope protein ion channelPLoS Pathog.20095e100051110.1371/journal.ppat.10005112702000
  • LiuJThe membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopesJ. Infect. Dis.20102021171118010.1086/656315
  • LiuWJT-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoVAntivir. Res.2017137829210.1016/j.antiviral.2016.11.006
  • YangYThe structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonistsProtein Cell2013495196110.1007/s13238-013-3096-84875403
  • ZhaoJRapid generation of a mouse model for Middle East respiratory syndromeProc. Natl Acad. Sci. USA20141114970497510.1073/pnas.13232791113977243

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.